549 related articles for article (PubMed ID: 24724599)
1. Cost-effectiveness of mammography screening for breast cancer in a low socioeconomic group of Iranian women.
Barfar E; Rashidian A; Hosseini H; Nosratnejad S; Barooti E; Zendehdel K
Arch Iran Med; 2014 Apr; 17(4):241-5. PubMed ID: 24724599
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of screening women with familial risk for breast cancer with magnetic resonance imaging.
Saadatmand S; Tilanus-Linthorst MM; Rutgers EJ; Hoogerbrugge N; Oosterwijk JC; Tollenaar RA; Hooning M; Loo CE; Obdeijn IM; Heijnsdijk EA; de Koning HJ
J Natl Cancer Inst; 2013 Sep; 105(17):1314-21. PubMed ID: 23940285
[TBL] [Abstract][Full Text] [Related]
3. Performance goals for an adjunct diagnostic test to reduce unnecessary biopsies after screening mammography: analysis of costs, benefits, and consequences.
Lee CI; Bensink ME; Berry K; Musa Z; Bodnar C; Dann R; Jarvik JG; Lehman CD; Ramsey SD
J Am Coll Radiol; 2013 Dec; 10(12):924-30. PubMed ID: 24295942
[TBL] [Abstract][Full Text] [Related]
4. Estimating personal costs incurred by a woman participating in mammography screening in the National Breast and Cervical Cancer Early Detection Program.
Ekwueme DU; Hall IJ; Richardson LC; Gardner JG; Royalty J; Thompson TD
Cancer; 2008 Aug; 113(3):592-601. PubMed ID: 18536027
[TBL] [Abstract][Full Text] [Related]
5. Program-specific cost-effectiveness analysis: breast cancer screening policies for a safety-net program.
Melnikow J; Tancredi DJ; Yang Z; Ritley D; Jiang Y; Slee C; Popova S; Rylett P; Knutson K; Smalley S
Value Health; 2013; 16(6):932-41. PubMed ID: 24041343
[TBL] [Abstract][Full Text] [Related]
6. Dutch digital breast cancer screening: implications for breast cancer care.
Timmers JM; den Heeten GJ; Adang EM; Otten JD; Verbeek AL; Broeders MJ
Eur J Public Health; 2012 Dec; 22(6):925-9. PubMed ID: 22158996
[TBL] [Abstract][Full Text] [Related]
7. Cost-Effectiveness Analysis of Breast Cancer Screening in Rural Iran.
Zehtab N; Jafari M; Barooni M; Nakhaee N; Goudarzi R; Larry Zadeh MH
Asian Pac J Cancer Prev; 2016; 17(2):609-14. PubMed ID: 26925651
[TBL] [Abstract][Full Text] [Related]
8. Breast cancer screening policies in developing countries: a cost-effectiveness analysis for India.
Okonkwo QL; Draisma G; der Kinderen A; Brown ML; de Koning HJ
J Natl Cancer Inst; 2008 Sep; 100(18):1290-300. PubMed ID: 18780864
[TBL] [Abstract][Full Text] [Related]
9. The National Cancer Screening Program for breast cancer in the Republic of Korea: is it cost-effective?
Kang MH; Park EC; Choi KS; Suh M; Jun JK; Cho E
Asian Pac J Cancer Prev; 2013; 14(3):2059-65. PubMed ID: 23679319
[TBL] [Abstract][Full Text] [Related]
10. Benefits, harms, and cost-effectiveness of supplemental ultrasonography screening for women with dense breasts.
Sprague BL; Stout NK; Schechter C; van Ravesteyn NT; Cevik M; Alagoz O; Lee CI; van den Broek JJ; Miglioretti DL; Mandelblatt JS; de Koning HJ; Kerlikowske K; Lehman CD; Tosteson AN
Ann Intern Med; 2015 Feb; 162(3):157-66. PubMed ID: 25486550
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of population-based service screening with mammography for women ages 40 to 49 years with a high or low risk of breast cancer: socioeconomic status, parity, and age at birth of first child.
Hellquist BN; Czene K; Hjälm A; Nyström L; Jonsson H
Cancer; 2015 Jan; 121(2):251-8. PubMed ID: 25242087
[TBL] [Abstract][Full Text] [Related]
12. [Economic evaluation of the new national breast cancer screening programme in France: application to the Bouche-du-Rhone district].
Giorgi R; Reynaud J; Wait S; Seradour B
Bull Cancer; 2005 Nov; 92(11):995-1001. PubMed ID: 16316834
[TBL] [Abstract][Full Text] [Related]
13. Breast MRI screening for average-risk women: A monte carlo simulation cost-benefit analysis.
Mango VL; Goel A; Mema E; Kwak E; Ha R
J Magn Reson Imaging; 2019 Jun; 49(7):e216-e221. PubMed ID: 30632645
[TBL] [Abstract][Full Text] [Related]
14. Mammography screening for breast cancer in Copenhagen April 1991-March 1997. Mammography Screening Evaluation Group.
Lynge E
APMIS Suppl; 1998; 83():1-44. PubMed ID: 9850674
[TBL] [Abstract][Full Text] [Related]
15. Costs, effects and cost-effectiveness of breast cancer control in Ghana.
Zelle SG; Nyarko KM; Bosu WK; Aikins M; Niëns LM; Lauer JA; Sepulveda CR; Hontelez JA; Baltussen R
Trop Med Int Health; 2012 Aug; 17(8):1031-43. PubMed ID: 22809238
[TBL] [Abstract][Full Text] [Related]
16. Computer-aided detection of breast cancer: a cost-effectiveness study.
Lindfors KK; McGahan MC; Rosenquist CJ; Hurlock GS
Radiology; 2006 Jun; 239(3):710-7. PubMed ID: 16569787
[TBL] [Abstract][Full Text] [Related]
17. Performance Goals for an Adjunct Diagnostic Test to Reduce Unnecessary Biopsies After Screening Mammography: Analysis of Costs, Benefits, and Consequences.
Lee CI; Bensink ME; Berry K; Musa Z; Bodnar C; Dann R; Jarvik JG; Lehman CD; Ramsey SD
J Am Coll Radiol; 2016 Nov; 13(11S):R81-R88. PubMed ID: 27814820
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of mammography, MRI, and ultrasonography for breast cancer screening.
Feig S
Radiol Clin North Am; 2010 Sep; 48(5):879-91. PubMed ID: 20868891
[TBL] [Abstract][Full Text] [Related]
19. The impact of alternative practices on the cost and quality of mammographic screening in the United States.
Burnside E; Belkora J; Esserman L
Clin Breast Cancer; 2001 Jul; 2(2):145-52. PubMed ID: 11899786
[TBL] [Abstract][Full Text] [Related]
20. [Mammography screening in Germany: how, when and why?].
Bick U
Rofo; 2006 Oct; 178(10):957-69. PubMed ID: 17021975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]